About Us

Contact Us

RCC
Home About Us Product News Order Career Contact

                                                                                                            

   

 

       
                                    TG101348, CAS:936091-26-8------A potent inhibitor of Janus kinase 2 (JAK-2)
 
 
       TG 101348, an oral agent, is a potent inhibitor of Janus kinase 2 (JAK-2), developed for the treatment of patients with myeloproliferative diseases including myelofibrosis (MF).

       TG 101348 is a TargeGen's flagship product.

      We have developed  the synthesis route of this drug for 10g scales. IN STOCK!

       We will pay more attention to this potent inhibitor and develop the process route. If you are interested, please contact us!

    

   

Declaration
 
Time:2011-05-20

 

Home About Us Product News Order Career Contact
 Copyright @ 2010-2011 APIs All rights reserved
 

 

 

No_Right_Click

 

No_Right_Click